Laobaixing Pharmacy (603883) - Total Assets
Based on the latest financial reports, Laobaixing Pharmacy (603883) holds total assets worth CN¥19.91 Billion CNY (≈ $2.91 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Laobaixing Pharmacy - Total Assets Trend (2011–2025)
This chart illustrates how Laobaixing Pharmacy's total assets have evolved over time, based on quarterly financial data. Also see 603883 company net worth for the company's overall valuation and market capitalisation.
Laobaixing Pharmacy - Asset Composition Analysis
Current Asset Composition (December 2025)
Laobaixing Pharmacy's total assets of CN¥19.91 Billion consist of 44.5% current assets and 55.5% non-current assets. Review 603883 total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.9% |
| Accounts Receivable | CN¥2.11 Billion | 10.6% |
| Inventory | CN¥3.65 Billion | 18.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥817.34 Million | 4.1% |
| Goodwill | CN¥5.61 Billion | 28.3% |
Asset Composition Trend (2011–2025)
This chart illustrates how Laobaixing Pharmacy's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Laobaixing Pharmacy for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laobaixing Pharmacy's current assets represent 44.5% of total assets in 2025, a decrease from 73.6% in 2011.
- Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 24.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 32.0% of total assets, an increase from 8.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 28.3% of total assets.
Laobaixing Pharmacy Competitors by Total Assets
Key competitors of Laobaixing Pharmacy based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
SHOP APOTH. UNSP.ADR/010
F:SAE1
|
Germany | €1.21 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.34 Billion |
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.13 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$347.87 Million |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.31 Billion |
Laobaixing Pharmacy - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.90 | 0.86 | 0.78 |
| Quick Ratio | 0.54 | 0.52 | 0.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.03 Billion | CN¥-1.45 Billion | CN¥-1.47 Billion |
Laobaixing Pharmacy - Advanced Valuation Insights
This section examines the relationship between Laobaixing Pharmacy's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.53 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -10.4% |
| Total Assets | CN¥19.85 Billion |
| Market Capitalization | $1.44 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Laobaixing Pharmacy's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Laobaixing Pharmacy's assets decreased by 10.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Laobaixing Pharmacy (2011–2025)
The table below shows the annual total assets of Laobaixing Pharmacy from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥19.85 Billion ≈ $2.90 Billion |
-10.44% |
| 2024-12-31 | CN¥22.16 Billion ≈ $3.24 Billion |
+4.36% |
| 2023-12-31 | CN¥21.23 Billion ≈ $3.11 Billion |
-0.78% |
| 2022-12-31 | CN¥21.40 Billion ≈ $3.13 Billion |
+26.18% |
| 2021-12-31 | CN¥16.96 Billion ≈ $2.48 Billion |
+50.28% |
| 2020-12-31 | CN¥11.28 Billion ≈ $1.65 Billion |
+13.70% |
| 2019-12-31 | CN¥9.92 Billion ≈ $1.45 Billion |
+16.97% |
| 2018-12-31 | CN¥8.48 Billion ≈ $1.24 Billion |
+26.66% |
| 2017-12-31 | CN¥6.70 Billion ≈ $980.26 Million |
+36.44% |
| 2016-12-31 | CN¥4.91 Billion ≈ $718.44 Million |
+29.18% |
| 2015-12-31 | CN¥3.80 Billion ≈ $556.14 Million |
+50.24% |
| 2014-12-31 | CN¥2.53 Billion ≈ $370.17 Million |
+16.06% |
| 2013-12-31 | CN¥2.18 Billion ≈ $318.96 Million |
+34.94% |
| 2012-12-31 | CN¥1.62 Billion ≈ $236.37 Million |
+6.25% |
| 2011-12-31 | CN¥1.52 Billion ≈ $222.46 Million |
-- |
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more